Clinical Trials Logo

Metabolic Disorders clinical trials

View clinical trials related to Metabolic Disorders.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05398783 Recruiting - Cancer Clinical Trials

A Natural History Study of Metabolic Sizing in Health and Disease

Start date: October 25, 2022
Phase:
Study type: Observational

Background: Scientists have long used simple measures (such as height and weight) to estimate how much a person s body uses food (calories) as energy, as commonly called the metabolic rate. But metabolism varies among people with similar body sizes. Scientists now believe the old formulas for estimating metabolic rates may not work well for all people. Researchers want to find more accurate ways to measure a person s metabolism. Objective: This natural history study will examine the relationships between metabolism, body composition, and body surface area in a wide range of people. Eligibility: Healthy children and adults aged 2 years or older. Also, people aged 2 years or older with conditions that may alter metabolism. These may include diabetes, obesity, renal disease, or cancer. Design: Participants will spend 2 days and 1 night in the hospital. They will provide a medical history and answer questions about their activity levels, the foods they eat, and their lifestyle. They will also eat a special diet. Participants will undergo many tests: They will lie in a bed with a clear hood covering their head for 30 to 45 minutes to measure the gases in their breath. They will lie on a padded table for about 15 minutes while their body is scanned. They will stand on a platform while a 3D scanner measures their body. They will have a test to measure how fast an electric signal moves through their body. They will grip an instrument to measure the strength of their hands. They will drink salty water and provide blood and urine samples. Participants may be invited to return for these 2-day visits up to 8 times per year. Return visits must be at least 2 weeks apart.

NCT ID: NCT03128996 Recruiting - Hemoglobinopathies Clinical Trials

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Start date: March 20, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

This study is designed to estimate the efficacy and toxicity of familial HLA mismatched bone marrow transplants in patients with non-malignant disease who are less than 21 years of age and could benefit from the procedure.

NCT ID: NCT02503384 Recruiting - Biliary Atresia Clinical Trials

Clinical and Basic Study for Pediatric Liver Transplantation

CBSPLT
Start date: July 2015
Phase: N/A
Study type: Observational

Background: In mainland China, the development of pediatric liver transplantation (LT) has lagged behind that of adult LT during the past two decades, but it has been progressing immensely in recent years. Renji hospital(shanghai) is currently the largest pediatric transplant center in mainland China. Aim and method: This study is performed for establishment of key techniques for pediatric LT in mainland China, including the indications and timing for pediatric LT, the criteria for donor selections, living donor LT planning, prevention and treatment for posttransplant complications, long-term follow-up management et al.

NCT ID: NCT02419898 Recruiting - Depression Clinical Trials

Oxfordshire Women and Their Children's Health

OxWATCH
Start date: April 2013
Phase:
Study type: Observational

The aim of this feasibility study is to test recruitment of participants into Phase 1 of the study and then the re-recruitment and retention of participants in Phase 2 of the study. The investigators will also be assessing the acceptability of recruitment strategy and data collection to participants. The effect of pre-pregnancy factors (biophysical, genetic, socioeconomic, behavioural and psychological) on obstetric, cardiovascular, socioeconomic, behavioural and psychological outcomes will all be examined.

NCT ID: NCT00920972 Recruiting - Hemoglobinopathies Clinical Trials

Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

Start date: December 2001
Phase: Phase 1/Phase 2
Study type: Interventional

The hypothesis for this study is that a preparative regimen that maximizes host immunosuppression without myeloablation will be well tolerated and sufficient for engraftment of donor hematopoietic cells. It is also to determine major toxicities from these conditioning regimens, within the first 100 days after transplantation.